Multiplex Immunoassay Approaches Using Luminex® xMAP® Technology for the Study of COVID-19 Disease. | Adv Exp Med Biol;1412: 479-489, 2023. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Multiplex Immunoassay Approaches Using Luminex® xMAP® Technology for the Study of COVID-19 Disease.

Das, Shubhagata; Dunbar, Sherry.

Affiliation

Das S; Luminex, A DiaSorin Company, Austin, TX, USA.
Dunbar S; Luminex, A DiaSorin Company, Austin, TX, USA.

Adv Exp Med Biol ; 1412: 479-489, 2023.

Article in En | MEDLINE | ID: mdl-37378784

Subject(s)
Key words

COVID-19; Immunoassay; MAP technology; Multiplex; Serological assay

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans Language: En Journal: Adv Exp Med Biol Year: 2023 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans Language: En Journal: Adv Exp Med Biol Year: 2023 Document type: Article Affiliation country: Country of publication: